Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine plus adrenaline injection for bleeding control in sinus endoscopy surgery
IRCT20251103067872N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of lidocaine and epinephrine in rhinosinusitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Intraoperative bleeding control. Started Nov 2025; status: completed.
02
Drugs
lidocaineepinephrine
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on IRCT20251103067872N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251103067872N1.